Aflac Incorporated (AFL)

Aflac has moved up in the past month, with the stock 9.68% higher over one month and trading at $127.11, 84% of the way up its 52-week range. The gain came after a November 4, 2026 report in which adjusted EPS of $2.43 beat the $1.80 estimate by 35.00%, though revenue shrank 31.00% year on year in the latest quarter. For investors the question is whether the trend and earnings strength can outweigh a sharp revenue decline and an analyst community that leans cautious, with the median 12-month target of $116.00 sitting below the current price.

The November 4, 2026 report was the clearest recent event. Adjusted EPS of $2.43 beat the analysts' estimate of $1.80 by 35.00%, and the share price rose 0.75% in the first session after the report. It was the third beat in the five most recent reports, and in none of the three beats did the shares fall in the first session. The two misses, in August and February, both produced moves in the stock that were not uniform: the August miss was followed by a 1.62% drop, while the February miss was followed by a 3.39% gain. The beats have not been matched by revenue. Net profit margin of 21.24% and operating margin of 17.43% show the business still earns well on the revenue it keeps, but a shrinking top line is the main point of concern for investors.

The price is 7.61% above its 50-day SMA and 9.07% above its 200-day SMA, and the 50-day average is 1.36% above the 200-day average. The stock is up 10.07% over six months and 11.71% over one year. The 14-day RSI reads 68.3, in the bullish zone and just short of overbought, and the MACD line is positive. Daily volatility is modest, with a typical daily move of 1.05% and a beta of 0.55 against the S&P 500, so the stock has moved more calmly than the market in recent months.

The trailing P/E of 18.40 is 11.5% above the sector median of 16.5, which is broadly in line with peers. The price-to-sales ratio of 3.79 is almost identical to the sector median of 3.8. Analysts are more cautious than the price action. Of 15 analysts with a current rating, 3 rate the stock buy or strong buy, 8 hold and 4 sell or strong sell, and there were three buy ratings three months ago out of 15. Recent actions in October and November 2026 were mostly reiterations, with Piper Sandler keeping its Overweight rating on November 9, 2026 and Mizuho and Barclays keeping Underperform and Underweight ratings on October 7, 2026. Insiders sold $254.0M of stock over the last 18 months across 119 sales and made no open-market purchases. Those sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases would be.

The base case is that AFL holds its gains while the trend stays intact: the price remains above its 20-day EMA of $122.89, its 50-day SMA of $118.12 and its 200-day SMA of $116.54, and the RSI stays in the bullish zone without reaching overbought levels. Analysts expect EPS to shrink 2.1% this fiscal year to $7.33 and then grow 4.9% next year to $7.69, while revenue is expected to shrink 3.4% this year, so the stock needs the earnings path to hold while top-line trends stabilise. The median analyst target of $116.00 sits 8.3% below the price, with a range from $101.00 to $143.00. A sustained move above the 52-week high of $131.19 would strengthen the bullish case, while a break below the 20-day EMA would suggest the recent rally is losing steam and would bring the 50-day SMA of $118.12 into position.

Support sits first at the 20-day EMA of $122.89, the nearest level below the price and a short-term trend line that the stock has stayed above. Next is the 50-day SMA at $118.12, followed by the 200-day SMA at $116.54, a longer-term average that sits close to it. The 52-week low of $105.76 is the deepest support level below the price. Resistance is the 52-week high of $131.19, the only level above the price, where a move would meet a level the stock has not exceeded in the past year.